6/12/2025CF PharmaTech Files for Hong Kong IPO

6/12/2025Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...

6/12/2025Cloudbreak Advances Ophthalmic Pipeline, Pursues Hong Kong IPO

6/12/2025InnoVec Raises Tens of Millions in Series A+ to Accelerate Gene Therap...

6/11/2025MediLink Therapeutics Lines Up Major Banks for Hong Kong IPO Push

6/11/2025JW Pharma Wins China Approval for Ertapenem Injection

6/11/2025Ligachem Inks Dual ADC Licensing Deals with CSPC Subsidiary Novarock

6/11/20253Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...

6/10/2025BIOSeedin 2025 Showcases China's Rise as Global Biotech Innovator

6/10/2025Pfizer CEO Highlights Chinese Data Due Diligence to Support $6B Bispec...

6/10/2025Gavi Launches $224M Arbitration Claim Against Clover Biopharma Over CO...

6/10/2025Merck KGaA's Pimicotinib NDA Accepted by CDE in China, Setting Course ...

6/10/2025NH's DB6: China's Consumer Healthcare Market Underperformed Again in 2...

6/10/2025CDE Seeks Comments on Draft Guidelines for Defining and Classifying Ad...

6/10/2025CDE Seeks Public Feedback on Second Batch of 2025 External Expert Addi...

6/10/2025Transpire Enters License Deal with Intragrand Pharma for Investigation...

6/10/2025Green Valley Halts Sales of Alzheimer's Drug GV-971 Amid Regulatory Un...

6/10/2025Innogen Pharma Files for Hong Kong Listing, Accelerates Pipeline Devel...

6/10/2025GenEditBio Doses First Patient in World’s First In Vivo CRISPR Trial ...

6/9/2025Kelun-Biotech Secures US$250M in Upsized HK Share Placement

6/9/2025Everest Presents Positive Results from Phase 1b/2a Trial of EVER001 fo...

6/9/2025Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted

6/9/2025China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs

6/9/2025CDE Solicits Comments on Draft Guidance on Post-Approval Change Manage...

6/9/2025YolTech's YOLT‑101 Wins FDA IND Clearance as China Licensee Salubris ...

6/9/2025Livzon's siRNA Candidate YJH‑012 Approved for Clinical Entry in China

6/9/2025Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hypertension

6/7/2025Recent Executive Moves

6/7/2025QureBio Secures ~CNY 100M in Series C1 Financing to Advance BsAb Thera...

6/6/2025Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...

Page:13/56 Total number of articles:1675: [First][<<] [11] [12] [13] [14] [15] [>>] [End]